VEGFA and Alzheimer disease: In contrast, the levels of eotaxin and VEGF were lower in the GGDE-treated mice (100 and 500 mg/kg) than in the SI-AD mice, and the TNF-α and IL-13 levels were lower in the GGDE100 group than in the SI-AD group.